Subsequently, we conducted immunohistochemistry (IHC) analysis on tumor tissues using a commercial breast cancer tissue microarray (TMA) to assess OPA1/3 expression (Fig. 2C&D). This evidence concerns the gene OPA1 and breast carcinoma.